Review
[The antigenic and immunogenic substances in mycobacteria and the problem of creating a molecular vaccine]
[Article in
Russian]
- PMID: 2516948
Item in Clipboard
Review
[The antigenic and immunogenic substances in mycobacteria and the problem of creating a molecular vaccine]
[Article in
Russian]
Zh Mikrobiol Epidemiol Immunobiol.
1989 Dec.
No abstract available
Similar articles
-
Heterologous Boost Following Mycobacterium bovis BCG Reduces the Late Persistent, Rather Than the Early Stage of Intranasal Tuberculosis Challenge Infection.Front Immunol. 2018 Oct 30;9:2439. doi: 10.3389/fimmu.2018.02439. eCollection 2018. Front Immunol. 2018. PMID: 30425711 Free PMC article.
-
A new vaccine against tuberculosis affords greater survival after challenge than the current vaccine in the guinea pig model of pulmonary tuberculosis.Infect Immun. 2003 Apr;71(4):1672-9. doi: 10.1128/IAI.71.4.1672-1679.2003. Infect Immun. 2003. PMID: 12654780 Free PMC article.
-
Mycobacterium bovis BCG-based vaccines against tuberculosis: novel developments.Vaccine. 2003 Jan 30;21(7-8):667-70. doi: 10.1016/s0264-410x(02)00577-7. Vaccine. 2003. PMID: 12531337 Review.
-
Evaluation of Immunogenicity and Protective Efficacy Elicited by Mycobacterium bovis BCG Overexpressing Ag85A Protein against Mycobacterium tuberculosis Aerosol Infection.Front Cell Infect Microbiol. 2016 Jan 28;6:3. doi: 10.3389/fcimb.2016.00003. eCollection 2016. Front Cell Infect Microbiol. 2016. PMID: 26858942 Free PMC article.
-
Rational design of antituberculosis vaccines: impact of antigen display and vaccine localization.Biologicals. 1997 Jun;25(2):169-73. doi: 10.1006/biol.1997.0079. Biologicals. 1997. PMID: 9236047 Review. No abstract available.